title: [Modern Diagnosis and Therapy of the rhinitis allergica].
abstract: The prevalence of allergic diseases is increasing worldwide. The highest increase rate is observed in rhinitis allergica. Apart from the anamnesis, the diagnosis relies mainly on skin tests, laboratory analyses and if necessary provocation tests. Symptomatic and causal therapy with abstention and specific immunotherapy are available as therapeutic means. Specific immunotherapy should be aspired as the method of choice. It is comprised of subcutane and sublingular immunity therapy. Usually native allergens and allergoids are used as therapeutics. Recombinant allergens are currently under development. Modern therapy procedures involving these drugs consist of year-round or pre- and co-seasonal treatment which spans at least 3-4 years. In cases of polyvalent allergy, different types of drugs and therapy procedures can be combined. The future of rhinitis allergica treatment lies in further development of specific immunotherapy.
authors.affiliation: Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde, Uniklinikum Dresden.
authors.forename: B
authors.initials: B
authors.lastname: Hauswald
authors.affiliation: Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde, Uniklinikum Dresden.
authors.forename: Y M
authors.initials: YM
authors.lastname: Yarin
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D003233:Conjunctivitis, Allergic / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D003430:Cross-Sectional Studies; D003888:Desensitization, Immunologic / Q000379:methods; D005512:Food Hypersensitivity / Q000175:diagnosis / Q000276:immunology / Q000628:therapy; D005858:Germany; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D007428:Intradermal Tests; D010328:Patch Tests; D012221:Rhinitis, Allergic, Perennial / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*
chemical_list: D007073:Immunoglobulin E